← All companies
CRBP
Corbus Pharmaceuticals Holdings, Inc.
$9.40
+0.48 +5.38%
Key statistics
from XBRL data in SEC filingsMarket cap
$174M
Revenue (TTM)
$97.3K
Net income (TTM)
-$84.5M
EPS (TTM)
$-5.74
P/E ratio
—
Dividend yield
—
Free cash flow
-$64.5M
Cash
$25.7M
Total assets
$144M
Gross margin
—
52-week range
$7.12 – $20.56
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Entered a material agreement; Regulation FD disclosure
Jul 6, 2026
8-K
Regulation FD disclosure; Other events
May 26, 2026
8-K
Entered a material agreement; Director or officer change; Regulation FD disclosure
May 21, 2026
8-K
Director or officer change; Shareholder vote results; Regulation FD disclosure
May 14, 2026
10-Q
Quarter ended 2026-03-31
May 12, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
May 12, 2026
8-K
Director or officer change
Apr 16, 2026
8-K
Regulation FD disclosure; Other events
Apr 14, 2026
8-K
Director or officer change; Regulation FD disclosure; Other events
Apr 7, 2026
10-K
Fiscal year ended 2025-12-31
Mar 9, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Mar 9, 2026
8-K
Regulation FD disclosure
Feb 25, 2026
8-K
Regulation FD disclosure
Jan 12, 2026
8-K
Director or officer change
Dec 18, 2025
8-K
Regulation FD disclosure; Other events
Dec 11, 2025
10-Q
Quarter ended 2025-09-30
Nov 12, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 12, 2025
8-K
Entered a material agreement; Regulation FD disclosure
Nov 3, 2025
8-K
Other events
Oct 30, 2025
8-K
Regulation FD disclosure; Other events
Oct 20, 2025
8-K
Regulation FD disclosure; Other events
Sep 16, 2025
10-Q
Quarter ended 2025-06-30
Aug 5, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 5, 2025
8-K
Shareholder vote results; Other events
May 19, 2025
10-Q
Quarter ended 2025-03-31
May 6, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
May 6, 2025
8-K
Director or officer change
Mar 21, 2025
8-K
Director or officer change
Mar 18, 2025
10-K
Fiscal year ended 2024-12-31
Mar 11, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Mar 11, 2025
8-K
Regulation FD disclosure; Other events
Feb 14, 2025
8-K
Regulation FD disclosure; Other events
Dec 3, 2024
8-K
Other events
Nov 15, 2024
10-Q
Quarter ended 2024-09-30
Nov 7, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 7, 2024
8-K
Regulation FD disclosure; Other events
Nov 4, 2024
8-K
Other events
Sep 3, 2024
8-K
Director or officer change; Regulation FD disclosure
Aug 20, 2024
8-K
Regulation FD disclosure
Aug 6, 2024
10-Q
Quarter ended 2024-06-30
Aug 6, 2024